46.63
price down icon1.04%   -0.49
after-market Handel nachbörslich: 46.70 0.07 +0.15%
loading
Schlusskurs vom Vortag:
$47.12
Offen:
$47.07
24-Stunden-Volumen:
19.71M
Relative Volume:
0.67
Marktkapitalisierung:
$10.15B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
67.58
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-1.75%
1M Leistung:
-21.13%
6M Leistung:
+33.08%
1J Leistung:
+109.67%
1-Tages-Spanne:
Value
$46.03
$48.45
1-Wochen-Bereich:
Value
$46.03
$50.99
52-Wochen-Spanne:
Value
$18.32
$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Name
Firmenname
Hims Hers Health Inc
Name
Telefon
415-851-0195
Name
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Name
Mitarbeiter
1,637
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
HIMS's Discussions on Twitter

Vergleichen Sie HIMS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
HIMS
Hims Hers Health Inc
46.63 10.65B 1.78B 164.40M 236.51M 0.69
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.94 64.44B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.77 44.53B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.05 40.61B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.23 22.69B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
455.32 18.78B 3.08B 1.24B 1.07B 25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Eingeleitet KeyBanc Capital Markets Sector Weight
2025-06-23 Herabstufung Needham Buy → Hold
2025-06-04 Bestätigt Needham Buy
2025-04-29 Herabstufung TD Cowen Buy → Hold
2025-02-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2025-01-10 Herabstufung Citigroup Neutral → Sell
2025-01-07 Eingeleitet BTIG Research Buy
2024-12-17 Eingeleitet Morgan Stanley Overweight
2024-11-14 Herabstufung BofA Securities Buy → Underperform
2024-08-22 Eingeleitet Needham Buy
2024-08-09 Herabstufung Imperial Capital Outperform → In-line
2024-05-22 Herabstufung Citigroup Buy → Neutral
2024-04-16 Herabstufung Jefferies Buy → Hold
2024-04-10 Eingeleitet Canaccord Genuity Buy
2024-02-28 Hochstufung Imperial Capital In-line → Outperform
2024-02-26 Eingeleitet Leerink Partners Market Perform
2023-12-07 Eingeleitet Imperial Capital In-line
2023-07-28 Eingeleitet TD Cowen Outperform
2023-04-11 Eingeleitet Robert W. Baird Neutral
2023-02-09 Hochstufung Jefferies Hold → Buy
2022-11-08 Hochstufung BofA Securities Neutral → Buy
2022-11-08 Hochstufung SVB Leerink Mkt Perform → Outperform
2022-10-17 Herabstufung Piper Sandler Overweight → Neutral
2022-09-07 Eingeleitet Truist Hold
2022-07-15 Eingeleitet SVB Leerink Underperform
2022-04-14 Eingeleitet Guggenheim Buy
2022-04-01 Fortgesetzt Credit Suisse Outperform
2022-03-10 Eingeleitet Deutsche Bank Hold
2021-12-02 Eingeleitet Jefferies Hold
2021-11-11 Hochstufung Piper Sandler Neutral → Overweight
2021-07-06 Eingeleitet BofA Securities Neutral
2021-05-20 Hochstufung Credit Suisse Neutral → Outperform
2021-04-21 Eingeleitet Truist Hold
2021-03-09 Eingeleitet Credit Suisse Neutral
2021-03-02 Hochstufung Citigroup Neutral → Buy
2021-02-17 Eingeleitet Citigroup Neutral
2021-02-12 Eingeleitet Piper Sandler Neutral
2021-02-08 Eingeleitet Tigress Financial Buy
Alle ansehen

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

pulisher
Oct 29, 2025

LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc. - PR Newswire

Oct 29, 2025
pulisher
Oct 29, 2025

Best Healthcare Stocks To Add to Your WatchlistOctober 29th - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Hims to begin selling GLP-1 microdosing treatments - Sherwood News

Oct 29, 2025
pulisher
Oct 29, 2025

Microdosing Treatment Plans for Metabolic Health - Hims & Hers Newsroom

Oct 29, 2025
pulisher
Oct 29, 2025

1 Profitable Stock on Our Watchlist and 2 We Find Risky - The Globe and Mail

Oct 29, 2025
pulisher
Oct 28, 2025

Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative

Oct 28, 2025
pulisher
Oct 27, 2025

HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 27, 2025
pulisher
Oct 25, 2025

Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance

Oct 25, 2025
pulisher
Oct 25, 2025

Hims & Hers: Pioneering Customer-Centric Innovation with Premium Valuation - FXLeaders

Oct 25, 2025
pulisher
Oct 25, 2025

Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha

Oct 25, 2025
pulisher
Oct 24, 2025

Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Menopause Care Expansion Could Be a Game Changer for Hims & Hers Health (HIMS) - simplywall.st

Oct 24, 2025
pulisher
Oct 23, 2025

Shattering the Stigma around Menopause with Molly Sims in New York City - Hims & Hers Newsroom

Oct 23, 2025
pulisher
Oct 23, 2025

Telehealth Stock Could Rebound Off Long-Term Trendline - Schaeffer's Investment Research

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers Health, Inc. (HIMS) Stock forecasts - Yahoo

Oct 23, 2025
pulisher
Oct 23, 2025

1 Mid-Cap Stock Worth Your Attention and 2 We Avoid - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo

Oct 23, 2025
pulisher
Oct 22, 2025

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey

Oct 22, 2025
pulisher
Oct 22, 2025

Why Hims & Hers Stock Slipped Today - AOL.com

Oct 22, 2025
pulisher
Oct 22, 2025

Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

The Problems We’re Solving in Healthcare - Hims & Hers Newsroom

Oct 22, 2025
pulisher
Oct 22, 2025

Hims & Hers Advances AI-Powered Personalized Digital Healthcare - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Could Hims & Hers Health's (HIMS) Menopause Expansion Reveal a New Competitive Edge in Women's Care? - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Fitt Insider

Oct 21, 2025
pulisher
Oct 21, 2025

Hers Health Inc. stockJuly 2025 Outlook & Fast Entry and Exit Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers (HIMS) Faces Margin Concerns Amid Growth Plans - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You? - Barchart.com

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers rated Sector Weight at KeyBanc on margin worries - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

HIMS Stock Declines Despite Launch of New Specialty in Women's Health - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance (HIMS) - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

HIMS: Keybanc Initiates Coverage with 'Sector Weight' Rating | H - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Hers Health Inc. (82W) stock expanding market penetrationPortfolio Update Report & Precise Buy Zone Identification - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Investor Mood: Hers Health Inc. stock undervalued after correctionLong Setup & Long-Term Safe Investment Plans - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers CFO Okupe sells $662k in shares - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health CFO Sells Shares Under Trading Plan - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

HIMS CFO exercises options, sells 11,592 shares under Rule 10b5-1 - Stock Titan

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health: Roller Coaster Gift (NYSE:HIMS) - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms - Zacks Investment Research

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - sharewise.com

Oct 20, 2025
pulisher
Oct 20, 2025

Hers Health Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Avoiding Lag: Real-Time Signals in (HIMS) Movement - news.stocktradersdaily.com

Oct 18, 2025
pulisher
Oct 18, 2025

Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations - Yahoo Finance

Oct 18, 2025
pulisher
Oct 17, 2025

Should the New Menopause Specialty and CEO Share Sale Prompt a Closer Look at HIMS? - simplywall.st

Oct 17, 2025

Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic RDY
$13.41
price down icon 8.15%
$22.59
price up icon 2.12%
$10.27
price down icon 0.19%
$138.02
price down icon 6.35%
$455.32
price up icon 9.63%
Kapitalisierung:     |  Volumen (24h):